Stay updated on Pembrolizumab vs Docetaxel in Lung Cancer Clinical Trial

Sign up to get notified when there's something new on the Pembrolizumab vs Docetaxel in Lung Cancer Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Pembrolizumab vs Docetaxel in Lung Cancer Clinical Trial page

  1. Check
    5 days ago
    Change Detected
    Summary
    Publications section with KEYNOTE-010 results has been added, and the study's results dates and IPD sharing details have been updated.
    Difference
    0.4%
    Check dated 2025-11-03T01:25:50.000Z thumbnail image
  2. Check
    12 days ago
    No Change Detected
  3. Check
    33 days ago
    Change Detected
    Summary
    Summary: The page adds a government-operating-status notice and a v3.2.0 release tag, while removing the v3.1.0 tag. The new notice is the significant change, signaling updated operating status and potential transaction delays.
    Difference
    3%
    Check dated 2025-10-05T10:33:22.000Z thumbnail image
  4. Check
    40 days ago
    Change Detected
    Summary
    Upgrade from v3.0.2 to v3.1.0: version metadata updated; no substantive content changes detected.
    Difference
    0.1%
    Check dated 2025-09-28T03:23:42.000Z thumbnail image
  5. Check
    55 days ago
    Change Detected
    Summary
    Version updated from v3.0.1 to v3.0.2; the 'Back to Top' element was removed.
    Difference
    0.2%
    Check dated 2025-09-13T17:41:02.000Z thumbnail image
  6. Check
    62 days ago
    Change Detected
    Summary
    The web page has been updated from version 3.0.0 to version 3.0.1, indicating a revision in the content.
    Difference
    0.2%
    Check dated 2025-09-06T15:26:45.000Z thumbnail image
  7. Check
    69 days ago
    Change Detected
    Summary
    The web page has added specific facility names and locations related to Parkinson's Disease and various chemical compounds, while removing several related topics and terms, including those associated with lung cancer and various antineoplastic agents.
    Difference
    3%
    Check dated 2025-08-30T12:13:11.000Z thumbnail image

Stay in the know with updates to Pembrolizumab vs Docetaxel in Lung Cancer Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Pembrolizumab vs Docetaxel in Lung Cancer Clinical Trial page.